Philip Morris International Inc. (PMI) Holds 2022 Virtual Annual Meeting of Shareholders
04 Mai 2022 - 04:27PM
Business Wire
Regulatory News:
Philip Morris International Inc. (NYSE: PM) held its 2022 Annual
Meeting of Shareholders today. André Calantzopoulos, Executive
Chairman of the Board, addressed shareholders and answered
questions. Jacek Olczak, Chief Executive Officer, gave the business
presentation, which included an overview of PMI’s:
- efforts to support its employees, their families and others
impacted by the war in Ukraine;
- excellent performance in 2021 and strong start to 2022;
- robust business fundamentals and rapid progress on its
smoke-free transformation;
- investments in wellness and healthcare to drive long-term
growth;
- continued progress on sustainability, with recognition by
leading external stakeholders; and
- commitment to returning cash to shareholders.
"The recent months have been an extremely challenging time for
many in the PMI family given the war in Ukraine," said Jacek
Olczak, Chief Executive Officer. "Our primary concern is for our
people and their families, and we are doing everything in our power
to help them."
"Despite this tragic situation, and the related impacts on our
operations in the region and more broadly, the outlook for our
business excluding Russia and Ukraine remains strong and our
smoke-free ambition remains intact. We are off to a strong start to
the year, following an excellent performance in 2021, with robust
underlying momentum and a reacceleration in IQOS user growth.”
“We continue to prioritize returns to shareholders and have
increased the dividend for 14 consecutive years since the 2008
spin. In 2021, we raised the dividend by 4.2% to an annualized rate
of $5.00 per common share. In addition, since July 2021, we have
repurchased approximately $1 billion in shares as part of our
current three-year program.”
Approximately 81 percent of the shares entitled to vote were
represented at the meeting in person or by proxy. The shareholders:
elected 14 nominees for director; approved, on an advisory basis,
the compensation of named executive officers; approved the 2022
Performance Incentive Plan; ratified the selection of
PricewaterhouseCoopers SA as independent auditors; and voted
against the shareholder proposal. Final voting results will be
included in a Form 8-K that PMI will file with the SEC in the
coming days.
An archived copy of the webcast of the meeting will be available
for approximately one year from the date of the meeting at
www.virtualshareholdermeeting.com/PMI2022. The presentation slides
and script will be available at the same website address.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate and
commercialize innovative smoke-free products for adults who would
otherwise continue to smoke, with the goal of completely ending the
sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research,
as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as Modified Risk
Tobacco Products (MRTPs), finding that exposure modification orders
for these products are appropriate to promote the public health. As
of March 31, 2022, PMI's smoke-free products are available for sale
in 71 markets, and PMI estimates that approximately 12.7 million
adults around the world excluding Russia and Ukraine, have already
switched to IQOS and stopped smoking. With a strong foundation and
significant expertise in life sciences, in February 2021 PMI
announced its ambition to expand into wellness and healthcare areas
and deliver innovative products and solutions that aim to address
unmet consumer and patient needs. For more information, please
visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220503006324/en/
Philip Morris International Investor Relations: New York:
+1 (917) 663 2233 Lausanne: +41 (0)58 242 4666
InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2023 bis Mär 2024